All companies
Visit website
PhysiSens
OperatingPhysiSens LLC
Healthcare · Founded 2021
Medical device and startup in telerehabilitation/physiotherapy space
Post-money valuation ⓘ
$3.0M
As of Oct 2024 · from PhysiSens Class A Membership Unit 1 · pre-money + amount raised, not a traded price
Total raised
$17,550
Across 1 round since 2024
Latest share price
$1.00
PhysiSens Class A Membership Unit 1 offering price
Financials
FY2021–FY2024 · from SEC filings · hover any figure for its source$0
−$6K
2021
$3K
−$1K
2022
$0
−$9K
2023
$0
−$27K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$2,750
$0
$0
Cost of goods sold
$0
$0
$0
$0
Gross margin
—
100%
—
—
Net income
-$6,358
-$1,192
-$9,493
-$27,046
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$0
$0
$70
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$0
$0
$70
Short-term debt
$6,358
$7,550
$17,043
$28,374
Long-term debt
$0
$0
$0
$0
Total liabilities
$6,358
$7,550
$17,043
$28,374
Other
Headcount
—
1
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$3.0M
post-money
PhysiSens Class A Membership Unit 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $17.6K / $500KPost-money $3M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 3 annual reports (FY2023–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002008025Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.